Xeris Biopharma Holdings, Inc. (XERS) Financials

XERS Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 411.9 million 421.6 million
March 31, 2026 392.0 million 379.0 million
Dec. 31, 2025 383.5 million 369.8 million
Sept. 30, 2025 370.2 million 371.1 million

XERS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 8.1 million 11.1 million
March 31, 2026 9.5 million 4.1 million
Dec. 31, 2025 19.7 million 5.3 million
Sept. 30, 2025 18.1 million 7.6 million

XERS Net Income

No data available :(

XERS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 121.7 million 188.8 million 36.9 million
March 31, 2026 111.8 million 31.1 million 37.3 million
Dec. 31, 2025 111.0 million 31.5 million 37.8 million
Sept. 30, 2025 91.6 million 32.0 million 38.2 million

XERS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 172.8 million
March 31, 2026 177.6 million
Dec. 31, 2025 180.1 million
Sept. 30, 2025 177.6 million

XERS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 209000 10.7 million 61.0 million -
March 31, 2026 325000 8.8 million 53.1 million -
Dec. 31, 2025 333000 7.9 million 47.5 million -
Sept. 30, 2025 363000 7.5 million 46.5 million -

XERS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 92.1 million 12.5 million
March 31, 2026 83.1 million 13.3 million
Dec. 31, 2025 85.8 million 19.1 million
Sept. 30, 2025 74.4 million 11.0 million

XERS Revenue by Segment
Graph available only for paid members. Upgrade to see it.

XERS

Price: $8.60

52 week price:
5.25
10.08

Earnings Per Share: -0.10 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 485000

Market Capitalization: 1.5 billion

Links: